Improving time to optimal Staphylococcus aureus treatment using a penicillin-binding protein 2a assay

References

1. Alere 2016; PBP2a culture colony test. http://www.alere.com/en/home/product-details/pbp2a.html Accessed 7.31.2016
2. Bauer K. A., West J. E., Balada-Llasat J. M., Pancholi P., Stevenson K. B., Goff D. A.. 2010; An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis51:1074– –1080 [CrossRef][PubMed]
   [Google Scholar]
3. Bauer K. A., Perez K. K., Forrest G. N., Goff D. A.. 2014; Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin Infect Dis59:S134– –S145 [CrossRef][PubMed]
   [Google Scholar]
4. Brown J., Paladino J. A.. 2010; Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model. Pharmacoeconomics28:567– –575 [CrossRef][PubMed]
   [Google Scholar]
5. CDC 2014; The Center for Disease Control and Prevention: Core Elements of Hospital Antibiotic Stewardship Programs. http://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html Accessed 7.31.2016
6. CLSI 2016; Performance Standards for Antimicrobial Susceptibility Testing, twenty-sixth informational supplement. CLSI document M100-S26. Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
7. Cosgrove S. E., Sakoulas G., Perencevich E. N., Schwaber M. J., Karchmer A. W., Carmeli Y.. 2003; Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis36:53– –59 [CrossRef][PubMed]
   [Google Scholar]
8. Forrest G. N., Mehta S., Weekes E., Lincalis D. P., Johnson J. K., Venezia R. A.. 2006; Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J Antimicrob Chemother58:154– –158 [CrossRef][PubMed]
   [Google Scholar]
9. Mosammaparast N., McAdam A. J., Nolte F. S.. 2012; Molecular testing for infectious diseases should be done in the clinical microbiology laboratory. J Clin Microbiol50:1836– –1840 [CrossRef][PubMed]
   [Google Scholar]
10. Newcombe R. G.. 1998; Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med17:857– –872 [CrossRef][PubMed]
    [Google Scholar]
11. Nicolsen N. C., LeCroy N., Lecroy N., Alby K., Martin K. E., Laux J., Lin F. C., Daniels L., Weber D. J., Miller M. B.. 2013; Clinical outcomes with rapid detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from routine blood cultures. J Clin Microbiol51:4126– –4129 [CrossRef][PubMed]
    [Google Scholar]
12. Schweizer M. L., Furuno J. P., Harris A. D., Johnson J. K., Shardell M. D., McGregor J. C., Thom K. A., Cosgrove S. E., Sakoulas G., Perencevich E. N.. 2011; Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis11:279– –285 [CrossRef][PubMed]
    [Google Scholar]
13. TJC 2013; The Joint Commission: Antimicrobial Stewardship Toolkit SKU# FR1007. http://www.jcrinc.com/antimicrobial-stewardship-toolkit/ Accessed on 31 July 2016
14. TJC 2016; The Joint Commission: Joint Commission unveils new antimicrobial stewardship standard. https://www.jointcommission.org/issues/article.aspx?Article=8/edJxSI/ROgKZhv46xb1vQ5282rP1aYDfaGA3GiMJM%3D Accessed on 31 July 2016